Clinical trial
Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in…
NCT00386763 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00386763 |
|---|---|
| Title | Efficacy and Safety of the Pediatric Formulation of Artemether- Lumefantrine in Children With Uncomplicated P. Falciparum Malaria. |
| Official title | A Randomized, Investigator-Blinded, Multicenter, Parallel-Group Study to Compare Efficacy, Safety and Tolerability of Arthemeter/ Lumefantrine Dispersible Tablet Formulation vs. Artemether/ Lumefantrine 6-Dose Crushed Tablet in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in… |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria, Falciparum |
| Intervention type | Drug |
| Interventions | Artemether-lumefantrine |
| Enrollment | 890 |
| Start date | Aug 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Oct 12, 2006 |
| Last update posted | Mar 12, 2009 |
| Countries | Benin, Kenya, Mali, Mozambique, Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: